This Web Site is committed to the memory of Janis Morrow.

Human liver  

2010 Hepatitis C News

News Index


Other Pages Of Interest:

J&F Blog      New HCV Drugs     VIDEOS


March


Idenix Announces Data Presentations at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL

 HCV/Introduction to Supplements

New Evidence for Milk Thistle

Noninvasive diagnosis of small hepatocellular carcinoma

Diabetes Treatments Deemed Harmful

 Stroke victims in their 50s have battled back

Hepatitis C Virus Infection and Chronic Obstructive Pulmonary Disease 

Genotype 2 Extending Therapy With Peg/Riba

FDA Seeking Comments about Expanded Access for Direct-acting Antiviral Drugs for Hepatitis C

New CDC National Center for Health Statistics Report Looks at Trends in Hepatitis A, B, and C

March 16

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression  

Telaprevir Coinfection Study Open - Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients

High-risk lifestyle

This and That From Hepc.bull newsletter

Neutropenia: Research Findings Expected to Ease Treatment of Low Neutrophil Counts in Cancer Patients

HCV newsletter March

Obesity And Alcohol In Increasing The Risk Of Liver Disease

March 14

FDA Hearing on HCV Oral Drugs Early Access

Suppression of Hepatitis C Viral Load Reduces Insulin Resistance

Can Liver Cancer Be Found Early?

Causes of Easy Bruising

Get tested if you were tattooed or pierced at Colborne home

Repost/Pegasys or PegIntron/Which FDA Approved Drug Is Better for Treating Hepatitis C ?

March 11

Hepatitis C And Insulin Resistance - Surprising Findings

Link Between Hepatitis C And Insulin Resistance Surprises Scientists

Artist raising awareness of hepatitis C

Video/Live kidney donation safe

Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell

Age in HCV

Board votes against medical marijuana ban

Management of varices and variceal hemorrhage in cirrhosis

Safer Blood Transfusions

Inhibitex to Present at Two Upcoming Conferences

University of Michigan scientists discover bone marrow can harbor HIV-infected cells

March 10

Hepatitis C For Fools Part one and two

Vertex Maps Out Combo Drug Game Plan for Treating Hepatitis C

Differentiate Liver Fibrosis From Steatohepatitis

White blood cells answer to a HCV Vaccine?

Researchers probe Hep C-diabetes link

Campaign On Hepatitis C

Post-Op Liver Cancer Complications More Frequent At Low-Volume Hospitals

Cirrhosis

Financial assistance HCV Drugs

Treating With Pegylated Interferon plus Ribavirin and have not reached UD at 12 wks you may be wondering what's next?

Gluten and Your Liver

steatosis in chronic hepatitis C infection

March 8

Vertex Will Study All-Oral Regimen of HCV Protease Inhibitor Telaprevir plus Polymerase Inhibitor VX-222

Avail Clinical Research Announces Hepatitis C Research Studies in DeLand, FL

How to evaluate hemodynamics of gastric varices effectively?

Rock stars highlight hepatitis C risks

US doctors sanction transplant criteria for liver cancer patients

Miracle Cancer Drug Extends Life

March 6

Abbott, Enanta moving Hepatitis C drug development

Test Results in Hepatitis C Infection

Targeted Delivery Of Losartan Reduces Liver Inflammation And Scarring

Ghrelin Mitigates Liver Fibrosis In Animal Models; Regulates Human Fibrosis

Milk Thistle for the Liver -- Any Evidence?

My Hepatitis C & Liver Transplant Video Diary

March 3

Chronic Hepatitis C body weight and disease progression

Study Casts Doubt on Virus Link to Chronic Fatigue

What Is Alcoholic Liver Disease? What Is Alcoholic Hepatitis?

Reliable Biomarkers Needed For Early Detection Of Liver Cancer

Vertex Broadens its Commitment to Improving HCV Care with Clinical Trial to Evaluate Combination Regimens Based on Oral Antiviral Therapies

Avila to start trials of drug for hepatitis C

March 1

Off Topic/ More Evidence of Marijuana-Psychosis Link

HCV Advocate Newsletter :
March 2010

Disease progression of hepatitis C

HCV Treatment in People with Fibrosis & Cirrhosis

Shorter Treatment for HCV Genotype 1?

HCV Found in Atherosclerosis

Plaques Kidney Disease in HIV/HCV Coinfection

Treatment of Injection Drug Users 

Partial Immunity to HCV?

Occult hepatitis C virus infection: what does it mean?


February


Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection

Avila Aims to Trump Vertex With Drug that Hits Hepatitis C Virus and Won’t Let Go

Feb 26


Hepatitis C Treatment/Getting Ready

Deciding Not To Treat HCV/What Next?

HIV patients on antiretoviral drugs age before their time

Bleeding Esophageal Varices

No serious adverse events seen in ANA598 patients

Off Topic/A Worthwhile Cause

30-year term for surgical tech who swapped infected needles video

Feb 25


Easing Liver Inflammation: Balancing Omega-3’s and Omega-6’s

AST-120 Used to Treat Hepatic Encephalopathy

Stem Cells In The Treatment Of Cirrhosis

NS5A protein from hepatitis C virus genotype 3a

Mouse Gets Human Liver

Unaware they are infected with HBV and HCV

Successful hepatitis C treatment reduces HIV disease progression and non-liver-related mortality

HCV treatment-related anemia

Transplants Can Give Cirrhosis Patients a Brand-New Start

HCV Treatment Blog/Five Days Post TX

Ascites/Cirrhosis

non-nucleoside polymerase inhibitor for the treatment of HCV/ ANA598 development program

Feb 24


Fibromyalgia and HCV  

What Is a Healthy Stool ?

Hepatitis C is neglected

Feb 19


PEG-IFN/ribavirin: More Adverse Effects, Worse Adherence in Older HCV-1 Patients

Complete enrollment by Roche of the 12 week RG7128 Phase 2b study (PROPEL)

Brandon clinic's patients warned of hepatitis C outbreak

Feb 18


Can Some Genotype 1 Chronic Hepatitis C Patients Benefit from Shorter Interferon-based Treatment?

Racial/ethnic and Socioeconomic Disparities in Survival of People with Liver Cancer

Age at Time of HBeAg Seroconversion Predicts Chronic Hepatitis B Prognosis

Herpes/complex family of viruses from chickenpox and shingles to cold sores

Promise in Fight Against Hepatitis C

Pipeline of anticipated new drugs to treat hepatitis C

Feb 16


Herbal Remedies/Milk Thistle/Hepatitis C Hour Video

HCV/Difference between standard vaccines and DNA vaccines

Feb 15


Polymerase/Protease Inhibitors- Will IFN-α and ribavirin remain cornerstones of future HCV treatment options

Hepatitis B and C Management

Can HCV Be A Mild Disease? W-Normal ALT

Telaprevir or Boceprevir

Feb 13


What's Going On In My Liver ?

New Test, Treatments for Hepatitis C

Liver Cancer/Interview Podcast

Unique Family of Anti-Cancer Compounds

Pegasys produces a higher rate of (SVR) sustained virological response in patients with chronic (HCV)

Telaprevir/Boceprevir New Drugs Alters Treatment Decisions in Hepatitis C

Inflamed liver/acute hepatotoxicity associated with the weight-loss product Hydroxycut Hardcore".

Locteron Interim Phase IIb

Resistance to direct antiviral agents in Hep C

Biolex Announces Locteron(R) Phase 2b Interim Results In Hepatitis C Accepted For Presentation At EASL Conference

Feb 12


Blueberries Counteract Intestinal Diseases

Novartis licenses hep C drug from Debiopharm

Dynavax Reports Promising Early Clinical Trial Data for Experimental Hepatitis C Drug SD-101

Dynavax Initiates Large-Scale Phase 3 Trial Of HEPLISAVTM

Entecavir (Baraclude) Improves Liver Function in Chronic Hepatitis B Patients with Decompensated Cirrhosis

Nurse Whistle-Blower Charged for Reporting Doctor

Advantage of IFN-beta/alpha2b same-day administration for ribavirin-intolerant patients with chronic hepatitis C

Feb 09


Don't Fatten Your Liver

Liver Tests Alt/Ast/AFP Elevated and Normal Values

NVHR: Stop Liver Cancer 'Dead In Its Tracks' By Closing Funding Gap For Viral Hepatitis Education, Screening Programs

Delcath Systems Begins Data Analysis Of Phase III Trial

Frontiers in Drug Development for Viral Hepatitis

Hepatitis C 'Breakthrough'

Pain and Mood in Fibromyalgia

Feb 08


In Case You Missed It

Vertex’s telaprevir, Schering Plough’s boceprevir, and Human Genome Sciences’ Zalbin.

Feb 05


Video/Liver Cancer In HCV Cirrhosis and Interferon Feb 2010

Examining the role of miR-122 in hepatitis C Therapy

Conatus Pharmaceuticals Initiates Phase II Clinical Trial of CTS-1027 in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)

Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Program

WHAT'S NEW AT JANIS AND FRIENDS

Hepatitis C Milk Thistle/Herbs/Nutrition and Diet

Feb 04


American Heart Month/HCV Risk for Heart Disease?

Update Video Feb 04 2010/ Fibromyalgia

Acutely Damaged Livers May Be Repaired Via Transplanted Hepatocytes

Cell-Culture And Animal Tests Show Antiviral Could Provide Protection Against HIV, Ebola, Hepatitis C, Herpes And More

Feb 03


Mild Liver Fibrosis in HCV/Progression

Experts say 40 percent of cancers could be prevented

First Cohort Dosing Completed in Clinical Trial of HCV Polymerase Inhibitor ANA598

Reminder/Acetaminophen and Liver Damage

FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine)

HCV Diagnostic Tools: Grading & Staging a Liver Biopsy

Feb 02


VIDEO: Diet Influences Liver Disease Risk

Compound found that targets wide range of viruses

Liver Cirrhosis: Causes and complications

Hepatitis C treatment  telaprevir

Best Ablative Therapy for Small Liver Tumors Still Unclear

Decreased survival with elevated liver function tests

Outcomes for adult living liver donors

Quality of life in pediatric liver transplants

Beyond liver transplants: Acutely damaged livers may be repaired via transplanted hepatocytes

Of swine, birds and men -- pandemic H1N1 flu

BBC NEWS | Health | Steaming hot tea linked to cancer

Feb 01


 

From HCV Advocate; February

Hepatitis Journal Review :
January 2010

by Liz Highleyman

IOM Report
Alan Franciscus, Editor-in-Chief

HealthWise: Milk Thistle
Lucinda Porter, RN


HCV Drug Resistance
Liz Highleyman

Disability & Benefits: Social Security and Blue Book Listings
Jacques Chambers, CLU

 


January


Management of Depression During Hepatitis C Treatment with Interferon-based Therapy

Pharmasset Starts Trial of HCV Polymerase Inhibitor PSI-7977 for Genotype 1 Chronic Hepatitis C Patients

Transcatheter Arterial Chemoembolization Does Not Improve Survival in Liver Cancer Patients Undergoing Chemotherapy

"Transient elastography by Fibroscan is a non-invasive method for the diagnosis of liver fibrosis

Jan 28


We Can Cure HCV -

Treatment of Recent Hepatitis C Virus Infection Is Effective in Injection Drug Users, including those with HIV/HCV Coinfection

Jan 27


Lessons From HIV Therapy Applied to Viral Hepatitis Therapy: Summary of a Workshop

Achillion Pharma At A Glance

HCV Drug Update for Vertex, Roche, Idenix -

UPDATE 1-Dynavax hepatitis C drug shows promise in phase 1 trial

African-American Organ and Tissue Donors Changing History

Lab-grown Liver Cells Provide Model for Hepatitis C Infection

Potential New Class of Drugs to Combat Hepatitis C Identified

Liver Cancer/Unequal Outcomes Despite Equal Treatment

Hemopurifier® to reduce viral load in patients infected with Hepatitis-C virus

People Re-infected with Hepatitis C Are More Likely to Spontaneously Clear Virus, Indicating Partial Immunity

Long-term Entecavir (Baraclude) Produces Sustained Viral Suppression with Little Resistance in HBeAg Positive Chronic Hepatitis B Patients

Beyond The Ice: Technique For Preserving Pre-Transplant Livers Promises To Improve Patient Outcomes And Expand The Organ Pool

HCV & HBV Medicaid/Medicare Training by NYS DOH -

Jan 26


 
 
 
 
 
Jan 24
 
 
 
 
 
 
 
 
 
 
 
 
 
Jan 22
 
 
 
 
Jan 19
 
 
 
 
 
 
Jan 15
 
 
 
Read the hepc.bull -online monthly newsletter January 2010
 
 
 
 
Jan 14
 
 
 
 

Jan 12


 
 
 
 
 
 
 
 
 
 
 
Jan 11

 
 
 
 
 
 

Jan 08


 
 
 
 
 
 
 
Key to Hepatitis C May Be Two Cellular Proteins
 
 
 
 
 
 
 

 

Jan 08


 
 
 
 
 

Jan 06


 
 
 
 
 
 
 
 
 
Head To Head Study :  
 
Head-to-head studies identify best treatment regimen for hep C 

  
Peginterferon alpha-2a (PegIFNα2a); Commercial name Pegasys) May Yield higher response rate then Peginterferon Alpha-2b (PegIFNα2b); Commercial name Peg Intron.
 
In patients with chronic hepatitis C, treatment with peginterferon alpha-2a (PegIFNα2a) plus ribavirin (RBV) better suppresses the virus to undetectable levels in the blood than treatment with peginterferon alpha-2b (PegIFNα2b) plus RBV, according to two new head-to-head studies in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
 

Continue Reading......

 

Additional Reading

Do Differences in Pegylation of Interferon Alfa Matter?, 23 November 2009

FREE
Stefan Zeuzem
pages 34-36

Preview | Full Text | Full-Text PDF (233 KB)


 

Black HIV/HCV Coinfected Patients Experience Slower HCV Decline and Are Less Likely than Whites to Respond to Hepatitis C Treatment

Experts praise scheme to tackle hepatitis C

Jan 5


 

Transplant Rules May Change after Amoebic Disease Found

A "Family" of Friends

The Mysterious Condition of Fibromyalgia

Jan 2

Researchers keep hepatitis C at bay after liver transplant

Liver Cirrhosis- The Lesser-Known Silent Killer

Risk of Hepatitis : Pilferage of hospital waste

Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: A comparative analysis of nine scoring methods

Optimal length of antiviral therapy in patients with hepatitis C virus genotypes 2 and 3: a meta-analysis

Snoring And Liver Disease Linked By Low Oxygen Levels

From HCV Advocate

HBV Journal Review: January 2010, by Christine Kukka

HCV Advocate Newsletter, January 2010

Quality of Life: Effects of Hepatitis C and Its Treatment

HEALTHWISE:  Surviving the Winter with Hepatitis C

AASLD 2009: Part 1    AASLD 2010: Part 2

Top Stories 2009

HEPATITIS JOURNAL REVIEW
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


copyright © 2003-2008 Janis and Friends Hepatitis C Web Site|  design )by carter

Design downloaded from Zeroweb.org: Free website templates, layouts, and tools.